🔥🐔 BizChicken 🐔🔥
Companies Similar to Ocugen, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Eyenovia, Inc.
Optejet
Eyenovia, Inc. is focused on developing therapeutic solutions for ophthalmic conditions using its proprietary microdose array print platform and Optejet delivery system. It targets conditions like progressive myopia, presbyopia, and mydriasis.
Symbol: EYEN
Recent Price: $0.11
Industry: Biotechnology
CEO: Mr. Michael M. Rowe
Sector: Healthcare
Employees: 57
Address: 295 Madison Avenue, New York, NY 10017
Phone: 917 289 1117
Leadership
- Charles Mather, Chairman of the Board
- Ellen Strahlman, MD, MS, Independent Director
- Sean Ianchulev, MD, MPH, Director
- Michael Geltzeiler, Independent Director
- Rachel Jacobson, Independent Director
- Ram Palanki, PharmD, Independent Director
- Michael Rowe, Director
Last updated: 2024-12-31
Genelux Corporation
Olvi-Vec
Genelux Corporation is a clinical-stage biopharmaceutical company developing oncolytic viral immunotherapies for tough-to-treat cancers, with a lead product candidate, Olvi-Vec.
Management | Directors | About | Management | Directors | About | Contact | Contact | Contact | Careers | Careers | About | About | About | About | About
Symbol: GNLX
Recent Price: $2.40
Industry: Biotechnology
CEO: Mr. Thomas Zindrick J.D.
Sector: Healthcare
Employees: 24
Address: 2625 Townsgate Road, Westlake Village, CA 91361
Phone: 858 483 0024
Leadership
- Bob Smith, CTO
- THOMAS ZINDRICK, J.D., Chairman
- JAMES L. TYREE, MBA, Lead Independent Director
- MARY MIRABELLI, MBA, Chair, Nominating and Corporate Governance Committee
- JOHN THOMAS, M.A., MBA, Ph.D., Chair, Audit Committee
- JOHN SMITHER, Chair, Compensation Committee
- Alice Johnson, CEO
- Carol Davis, CFO
- David Wilson, Chairman
- Eva Brown, Director
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Acumen Pharmaceuticals, Inc.
ACU193
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapies for Alzheimer's disease, with a key drug candidate ACU193 targeting amyloid-beta oligomers.
About | Contact | Careers | Careers | Leadership | About | About | Careers | About | About | About | About
Symbol: ABOS
Recent Price: $1.75
Industry: Biotechnology
CEO: Mr. Daniel J. O'Connell M.B.A.
Sector: Healthcare
Employees: 51
Address: 427 Park Street, Charlottesville, VA 22902
Phone: 434 297 1000
Last updated: 2024-12-31
Adverum Biotechnologies, Inc.
ADVM-022
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company focused on developing gene therapy product candidates for the treatment of ocular and rare diseases. Their lead product, ADVM-022, targets chronic retinal conditions such as wet age-related macular degeneration and diabetic macular edema.
Symbol: ADVM
Recent Price: $4.69
Industry: Biotechnology
CEO: Dr. Laurent Fischer
Sector: Healthcare
Employees: 121
Address: 800 Saginaw Drive, Redwood City, CA 94063
Phone: 650 656 9323
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
IRIDEX Corporation
Cyclo G6 laser system, IQ 532, and IQ 577 laser photocoagulation systems
IRIDEX Corporation is an ophthalmic medical technology company offering laser systems and devices for the treatment of sight-threatening eye diseases like glaucoma, diabetic macular edema, and retinal diseases.
About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: IRIX
Recent Price: $1.74
Industry: Medical - Devices
CEO: Mr. Patrick Mercer
Sector: Healthcare
Employees: 111
Address: 1212 Terra Bella Avenue, Mountain View, CA 94043
Phone: 650 940 4700
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
Ocugen, Inc.
OCU400, OCU410, OCU200
Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases. Its product pipeline includes gene therapy candidates targeting various retinal diseases and other conditions.
Symbol: OCGN
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shankar Musunuri M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 263 Great Valley Parkway, Malvern, PA 19355
Phone: 484 328 4701
Last updated: 2024-12-31
Ocuphire Pharma, Inc.
Nyxol
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.
Symbol: OCUP
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. George Magrath M.B.A., M.D., M.S.
Sector: Healthcare
Employees: 14
Address: 37000 Grand River Avenue, Farmington Hills, MI 48335
Phone: 248 681 9815
Last updated: 2024-12-31
Ovid Therapeutics Inc.
OV101, OV329, OV350, OV882, OV815
Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.
Our Story | Leadership | Directors | About | Our Story | Contact | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | About | Culture | Culture | About | Jobs | Careers | Careers | Jobs | About | About | About | Careers | Vision/Values | About | About | About | About | About | About
Symbol: OVID
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Sector: Healthcare
Employees: 40
Address: 1460 Broadway, New York, NY 10036
Phone: 646 661 7661
Leadership
- Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
- Meg Alexander, President and Chief Operating Officer
- Zhong Zhong, Ph.D., Chief Scientific Officer
- Jeffrey Rona, Chief Business and Financial Officer
- Amanda Banks, M.D., Chief Development Officer
- Julia Tsai, Ph.D., Senior Vice President of Clinical Development
- Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
- Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
- Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
- Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
- Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Sight Sciences, Inc.
OMNI Surgical System, Tear Care System
Sight Sciences, Inc., is a company focused on developing and commercializing surgical and nonsurgical technologies for treating eye diseases, including products like the OMNI Surgical System for glaucoma and Tear Care System for dry eye disease.
Symbol: SGHT
Recent Price: $3.53
Industry: Medical - Devices
CEO: Mr. Paul Badawi
Sector: Healthcare
Employees: 214
Address: 4040 Campbell Avenue, Menlo Park, CA 94025
Phone: 877 266 1144
Last updated: 2024-12-31
Unity Biotechnology, Inc.
UBX1325
Unity Biotechnology, Inc. engages in the research and development of therapeutics aimed at slowing, halting, or reversing diseases of aging with a focus on eye-related conditions.
Symbol: UBX
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Anirvan Ghosh Ph.D.
Sector: Healthcare
Employees: 19
Address: 285 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 416 1192
Last updated: 2024-12-31
MeiraGTx Holdings plc
Gene Therapy Treatments
Meira GTx Holdings plc is a clinical stage gene therapy company developing treatments for serious diseases, including ocular diseases, xerostomia, and neurodegenerative conditions. They are in various stages of clinical development for several gene therapy programs and have a research collaboration with Janssen Pharmaceuticals.
About | Leadership | About | Contact | About | About | About | News | About | About | About | Directors
Symbol: MGTX
Recent Price: $5.89
Industry: Biotechnology
CEO: Dr. Alexandria Forbes Ph.D.
Sector: Healthcare
Employees: 387
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 860 7985
Leadership
- Alexandria Forbes, Ph.D., Board Member, President and Chief Executive Officer
- Richard Giroux, Chief Operating Officer and Chief Financial Officer
- Stuart Naylor, Ph.D., Chief Development Officer
- Robert K. Zeldin, M.D., Chief Medical Officer
- Robert Wollin, JD, General Counsel and Secretary
- Alastair Leighton, Ph.D, SVP, Manufacturing and Supply Chain
- Christine Sheehy, SVP, Global Integration
- Tim Randall, SVP, Risk and Internal Controls
- Michel Michaelides, M.D., Head of Clinical Ophthalmology
- Tassos Georgiadis, Ph.D., Vice President, Preclinical Development
- Keith R. Harris, Ph.D., Chairman of the Board
- Ellen Hukkelhoven, Ph.D., Board Member
- Lord Mendoza, Independent Board Member
- Nicole Seligman, Independent Board Member
- Thomas E. Shenk, Ph.D., Independent Board Member
- Debra Yu, M.D., Independent Board Member
Last updated: 2024-12-31
Orgenesis Inc.
Point of Care (POCare) platform
Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.
About | Contact | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | News | Careers | Directors | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ORGS
Recent Price: $2.11
Industry: Biotechnology
CEO: Ms. Vered Caplan M.Sc.
Sector: Healthcare
Employees: 146
Address: 20271 Goldenrod Lane, Germantown, MD 20876
Phone: 480 659 6404
Last updated: 2024-12-31
Stoke Therapeutics, Inc.
STK-001, STK-002
Stoke Therapeutics, Inc. is an early-stage biopharmaceutical company focused on developing antisense oligonucleotide medicines to treat genetic diseases. Their lead product, STK-001, is aimed at treating Dravet syndrome, while STK-002 targets autosomal dominant optic atrophy.
Symbol: STOK
Recent Price: $10.80
Industry: Biotechnology
CEO: Dr. Edward M. Kaye M.D., Ph.D.
Sector: Healthcare
Employees: 110
Address: 45 Wiggins Avenue, Bedford, MA 01730
Phone: 781 430 8200
Leadership
- Edward M. Kaye, M.D., Chief Executive Officer & Director
- Jonathan Allan, J.D., General Counsel
- Isabel Aznarez, Ph.D., Senior Vice President, Discovery Research and Co-Founder
- Jason Hoitt, Chief Commercial Officer
- Dawn Kalmar, Chief Communications Officer
- Tommy Leggett, Chief Financial Officer
- Shamim Ruff, Chief Regulatory Officer
- Barry S. Ticho, M.D., Ph.D., FACC, Chief Medical Officer
- Joan Wood, Chief Human Resources Officer
- Adrian Krainer, Ph.D., Co-founder & Director
- Arthur Tzianabos, Ph.D., Chairman
- Jennifer Burstein, MBA, CPA, Director
- Seth L. Harrison, M.D., Director
- Arthur Levin, Ph.D., Director
- Garry E. Menzel, Ph.D., MBA, Director
- Ian F. Smith, Director
- Julie Anne Smith, Director
Last updated: 2024-12-31